Additionally, we stained for E-selectin, ICAM-1, and VCAM-1 on tumor endothelial cells roughly 24 hours post FUS+MBs BTB/BBB opening in intracranial B16F1cOVA and in the less immunogenic B16F1 tumors. This evidence concerns the gene SELE and neoplasm.